The DOI matches its Crossref record.
Genotype of 88 Toxoplasma gondii Isolates Associated with Toxoplasmosis in Immunocompromised Patients and Correlation with Clinical Findings
Abstract
We report the genotyping analysis of Toxoplasma gondii isolates in samples collected from 88 immunocompromised patients, along with clinical and epidemiological data. Most of these samples were collected in France during the current decade by the Toxoplasma Biological Resource Center. Lack of specific anti-Toxoplasma treatment, pulmonary toxoplasmosis, and involvement of multiple organs were the 3 main risk factors associated with death for this patient group. Genotyping results with 6 microsatellite markers showed that type II isolates were predominant among patients who acquired toxoplasmic infection in Europe. Non-type II isolates included 13 different genotypes and were mainly collected from patients who acquired toxoplasmosis outside Europe. Type III was the second most common genotype recovered from patients, whereas type I was rare in our population. Three nonarchetypal genotypes were repeatedly recovered from different patients who acquired the infection in sub-Saharan Africa (genotypes Africa 1 and Africa 2) and in the French West Indies (genotype Caribbean 1). The distribution of genotypes (type II vs. non-type II) was not significantly different when patients were stratified by underlying cause of immunosuppression, site of infection, or outcome. We conclude that in immunocompromised patients, host factors are much more involved than parasite factors in patients' resistance or susceptibility to toxoplasmosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Epidemiology of and Diagnostic Strategies for Toxoplasmosis
Robert-Gangneux, F., & Dardé, M.-L. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05013-11 · Cited by 1,815
Self-citationSu, C., Khan, A., Zhou, P., Majumdar, D., Ajzenberg, D., Dardé, M.-L., Zhu, X.-Q., Ajioka, J. W., Rosenthal, B. M., Dubey, J. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1203190109 · Cited by 379
Self-citationToxoplasma Effectors Targeting Host Signaling and Transcription
Hakimi, M.-A., Olias, P., & Sibley, L. D. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00005-17 · Cited by 339
Diagnosis, Treatment, and Prevention of Congenital Toxoplasmosis in the United States
Maldonado, Y. A., Read, J. S., & COMMITTEE ON INFECTIOUS DISEASES (2017) · Pediatrics · doi:10.1542/peds.2016-3860 · Cited by 270
Matta, S. K., Patten, K., Wang, Q., Kim, B.-H., MacMicking, J. D., & Sibley, L. D. (2018) · mBio · doi:10.1128/mbio.01393-18 · Cited by 52
Metadata
- Authors
- Ajzenberg, D., Yera, H., Marty, P., Paris, L., Dalle, F., Menotti, J., Aubert, D., Franck, J., Bessières, M., Quinio, D., Pelloux, H., Delhaes, L., Desbois, N., Thulliez, P., Robert‐Gangneux, F., Kauffmann‐Lacroix, C., Pujol, S., Rabodonirina, M., Bougnoux, M., Cuisenier, B., Duhamel, C., Duong, T. H., Filisetti, D., Flori, P., Gay‐Andrieu, F., Pratlong, F., Nevez, G., Totet, A., Carme, B., Bonnabau, H., Dardé, M., & Villena, I.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-15
- Volume
- 199
- Issue
- 8
- Pages
- 1155-1167
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2160273971
- Cited by
- 216
- References
- 0
- FWCI
- 10.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Genotype of 88 Toxoplasma gondii Isolates Associated with Toxoplasmosis in Immunocompromised Patients and Correlation with Clinical Findings. https://app.cochat.ai/papers/10.1086/597477
- The paper
- Ajzenberg, D., Yera, H., Marty, P., Paris, L., Dalle, F., Menotti, J., Aubert, D., Franck, J., Bessières, M., Quinio, D., Pelloux, H., Delhaes, L., Desbois, N., Thulliez, P., Robert‐Gangneux, F., Kauffmann‐Lacroix, C., Pujol, S., Rabodonirina, M., Bougnoux, M., . . . Villena, I. (2009). Genotype of 88 Toxoplasma gondii Isolates Associated with Toxoplasmosis in Immunocompromised Patients and Correlation with Clinical Findings. The Journal of Infectious Diseases. https://doi.org/10.1086/597477
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.